Zobrazeno 1 - 10
of 22
pro vyhledávání: '"E G Hanania"'
Autor:
L J Murray, Beth L Hill, Marilyn Travis, Ivan Plavec, E. G. Hanania, Katherine Olsson, Karin Luens-Abitorabi, Sean P. Forestell
Publikováno v:
Human Gene Therapy. 11:2039-2050
Absence of durable high-level expression of transgenes from Moloney murine leukemia (Mo-MuLV) retroviral vectors has been a hurdle in bringing effective gene therapy to the clinic. In this study we have analyzed transgene expression among the progeny
Autor:
Philippe Mazars, Mauricette Michallet, Gilles Salles, Anne Thiebaut, Denis Fiere, Tom Leemhuis, Kerry Atkinson, Eric Archimbaud, Hubert Godinot, Christopher L. Reading, Francis Lopez, Gilbert Fine, Bertrand Coiffier, Catherine Sebban, Chris Juttner, Pierre Biron, Nora Roubi, Irène Philip, E. G. Hanania, Thierry Philip
Publikováno v:
Experimental Hematology. 28:858-870
Objective The aims of our study performed in myeloma were to evaluate the performance and the safety of Systemix's high-speed clinical cell sorter, to assess the safety and efficacy of de-escalating cell dose cohorts of CD34 + Thy1 + hematopoietic st
Publikováno v:
Leukemia. 13:1833-1842
Non-Hodgkin's lymphoma (NHL) arises as a clonal transformation of normal B and T cell differentiation and is often characterized by a higher incidence of specific chromosomal translocations. We have developed real-time TaqMan PCR assays directed towa
Autor:
Z. Zu, Ronald J. Berenson, Robert C. Bast, R. E. Giles, Debra Ellerson, Gabriel N. Hortobagyi, Peter F. Thall, Michael Andreeff, D. Seong, R. E. Bird, Richard E. Champlin, Tong Wang, Creighton L. Edwards, John J. Kavanagh, Jeane P. Hester, Shelly Heimfeld, Martin Korbling, T. Holzmayer, Y. Su, A. Chang, Barbara Burtness, Richard J. Cote, E. G. Hanania, Andrzej P. Kudelka, Carlos Bachier, Frankie A. Holmes, Eugene Mechetner, Z. Rahman, Su Chun Cheng, J. M. Ostrove, David F. Claxton, Albert B. Deisseroth
Publikováno v:
Proceedings of the National Academy of Sciences. 93:15346-15351
To formally test the hypothesis that the granulocyte/macrophage colony-forming unit (GM-CFU) cells can contribute to early hematopoietic reconstitution immediately after transplant, the frequency of genetically modified GM-CFU after retroviral vector
Autor:
Debra Ellerson, Karen Janicek, Z. Zu, Joy Hamer, Patricia Tibbits, David F. Claxton, Martin Korbling, April G. Durett, Siqing Fu, Moshe Talpaz, Ronald J. Berenson, Hagop M. Kantarjian, Leslie Calvert, Jeane P. Hester, Shelly Heimfeld, Albert B. Deisseroth, Robert C. Moen, Michael Thomas, Christopher L. Reading, E. G. Hanania, Leah Goldberg, Richard E. Champlin, W. French Anderson
Publikováno v:
Blood. 83:3068-3076
Relapse after autologous bone marrow transplantation for chronic myelogenous leukemia (CML) can be due either to the persistence of leukemia cells in systemic tissues following preparative therapy, or due to the persistence of leukemia cells in the a
Publikováno v:
Cancer research. 58(17)
The complementarity determining region III of the rearranged immunoglobulin heavy chain gene has been the target for tumor-specific PCR assays for the detection and follow-up of B-cell malignancies. Previously, these assays have relied on gel-based e
Autor:
L. H. Yin, E. G. Hanania, Albert B. Deisseroth, J. J. Leffert, J. H. Won, Ronald G. Crystal, Giuseppe Pizzorno, R. E. Giles, Richard J. Cote, Barbara Burtness, J. Liang, W. L. Wang, T. Nanakorn, X. Y. Peng, E. Adams, Matthew R. Cooperberg, Siqing Fu, R. Brown, F. Garcia-Sanchez, D. S. Krause
Publikováno v:
Blood, vol 92, iss 2
Scopus-Elsevier
Garcia-Sanchez, F; Pizzorno, G; Fu, SQ; Nanakorn, T; Krause, DS; Liang, J; et al.(1998). Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: A potential purging method for autologous transplantation. Blood, 92(2), 672-682. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6g53q4pc
Europe PubMed Central
Scopus-Elsevier
Garcia-Sanchez, F; Pizzorno, G; Fu, SQ; Nanakorn, T; Krause, DS; Liang, J; et al.(1998). Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: A potential purging method for autologous transplantation. Blood, 92(2), 672-682. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6g53q4pc
Europe PubMed Central
Ad.CMV-CD is a replication incompetent adenoviral vector carrying a cytomegalovirus (CMV)-driven transcription unit of the cytosine deaminase (CD) gene. The CD transcription unit in this vector catalyzes the deamination of the nontoxic pro-drug, 5-fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6388da6c2c80507a405e675624d3028
https://escholarship.org/uc/item/6g53q4pc
https://escholarship.org/uc/item/6g53q4pc
Autor:
E G, Hanania, A B, Deisseroth
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(2)
Repeated exposures to high doses of chemotherapy are often required to eradicate solid tumors. The success of such high-dose therapy is often limited by the myelosuppressive and toxic effects of these drugs on bone marrow cells and by the intrinsic r
Publikováno v:
Cancer gene therapy. 2(4)
We initiated studies to investigate the involvement of the murine retinoblastoma (RB) gene in mammary carcinogenesis using cell lines derived from mammary glands of irradiated mice. We found that the RB mRNA levels as well as the amounts of the nucle
Autor:
Albert B. Deisseroth, R. E. Giles, John J. Kavanagh, Gabriel N. Hortobagyi, E. G. Hanania, Richard E. Champlin
Publikováno v:
The American journal of medicine. 99(5)
PURPOSE : To review the recent advances in the application of genetic modification strategies to the therapy of human diseases for which a molecular defect is known. METHODS : A computerized data bank search, the minutes of the National Institutes of